Epicore Biosystems, Inc. announced that it will issue 2,150,000 series A-1 preferred shares at issue price of $4.6541 per share for the gross proceeds $10,006,315 in funding on December 12, 2023. The shares are convertible and cumulative. The shares carry cumulative fixed dividend rate of 3% per annum.

The shares will be convertible in common shares at a fixed conversion price of $4.6541 per share. The round will be raised at post money valuation of $67,202,751. The shares are issued at a par value of $0.000001 per share.